VEGFA and liver dysplastic nodule: It can also inhibit vascular endothelial growth factor (VEGF)-mediated endothelial proliferation and migration and reduce VEGF-stimulated in vitro angiogenesis by directly repressing the transcript of FLK1 [30], which is closely correlated to the occurrence of DN.